Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Cell Death Differ ; 27(2): 742-757, 2020 02.
Article in English | MEDLINE | ID: mdl-31296963

ABSTRACT

Gastrointestinal epithelial cells provide a selective barrier that segregates the host immune system from luminal microorganisms, thereby contributing directly to the regulation of homeostasis. We have shown that from early embryonic development Bcl-G, a Bcl-2 protein family member with unknown function, was highly expressed in gastrointestinal epithelial cells. While Bcl-G was dispensable for normal growth and development in mice, the loss of Bcl-G resulted in accelerated progression of colitis-associated cancer. A label-free quantitative proteomics approach revealed that Bcl-G may contribute to the stability of a mucin network, which when disrupted, is linked to colon tumorigenesis. Consistent with this, we observed a significant reduction in Bcl-G expression in human colorectal tumors. Our study identifies an unappreciated role for Bcl-G in colon cancer.


Subject(s)
Colorectal Neoplasms/metabolism , Inflammation/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Animals , Colitis/metabolism , Colitis/pathology , Colorectal Neoplasms/pathology , Humans , Inflammation/pathology , Mice , Mice, Knockout , Proto-Oncogene Proteins c-bcl-2/deficiency , Proto-Oncogene Proteins c-bcl-2/genetics
2.
PLoS One ; 7(7): e41409, 2012.
Article in English | MEDLINE | ID: mdl-22844474

ABSTRACT

Alveolins, or inner membrane complex (IMC) proteins, are components of the subpellicular network that forms a structural part of the pellicle of malaria parasites. In Plasmodium berghei, deletions of three alveolins, IMC1a, b, and h, each resulted in reduced mechanical strength and gliding velocity of ookinetes or sporozoites. Using time lapse imaging, we show here that deletion of IMC1h (PBANKA_143660) also has an impact on the directionality and motility behaviour of both ookinetes and sporozoites. Despite their marked motility defects, sporozoites lacking IMC1h were able to invade mosquito salivary glands, allowing us to investigate the role of IMC1h in colonisation of the mammalian host. We show that IMC1h is essential for sporozoites to progress through the dermis in vivo but does not play a significant role in hepatoma cell transmigration and invasion in vitro. Colocalisation of IMC1h with the residual IMC in liver stages was detected up to 30 hours after infection and parasites lacking IMC1h showed developmental defects in vitro and a delayed onset of blood stage infection in vivo. Together, these results suggest that IMC1h is involved in maintaining the cellular architecture which supports normal motility behaviour, access of the sporozoites to the blood stream, and further colonisation of the mammalian host.


Subject(s)
Host-Parasite Interactions , Movement , Plasmodium berghei/cytology , Plasmodium berghei/physiology , Protozoan Proteins/metabolism , Sporozoites/cytology , Zygote/cytology , Animals , Cell Line, Tumor , Gene Knockout Techniques , Hepatocytes/parasitology , Life Cycle Stages , Liver/parasitology , Mice , Plasmodium berghei/growth & development , Plasmodium berghei/metabolism , Protozoan Proteins/genetics , Salivary Glands/parasitology , Sporozoites/metabolism , Time Factors , Zygote/metabolism
3.
J Clin Invest ; 122(6): 2301-5, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22565309

ABSTRACT

Effective control and eradication of malaria will require new tools to prevent transmission. Current antimalarial therapies targeting the asexual stage of Plasmodium do not prevent transmission of circulating gametocytes from infected humans to mosquitoes. Here, we describe a new class of transmission-blocking compounds, bumped kinase inhibitors (BKIs), which inhibit microgametocyte exflagellation. Oocyst formation and sporozoite production, necessary for transmission to mammals, were inhibited in mosquitoes fed on either BKI-1-treated human blood or mice treated with BKI-1. BKIs are hypothesized to act via inhibition of Plasmodium calcium-dependent protein kinase 4 and predicted to have little activity against mammalian kinases. Our data show that BKIs do not inhibit proliferation of mammalian cell lines and are well tolerated in mice. Used in combination with drugs active against asexual stages of Plasmodium, BKIs could prove an important tool for malaria control and eradication.


Subject(s)
Anopheles/parasitology , Focal Adhesion Kinase 2/antagonists & inhibitors , Malaria, Falciparum , Plasmodium berghei/enzymology , Plasmodium falciparum/enzymology , Protein Kinase Inhibitors/pharmacology , Protozoan Proteins/antagonists & inhibitors , Animals , Communicable Disease Control/methods , Focal Adhesion Kinase 2/metabolism , Humans , Malaria, Falciparum/enzymology , Malaria, Falciparum/prevention & control , Malaria, Falciparum/transmission , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...